Alongside the launch of our 2024 Sustainability Report, “Built to Last,” we marked World Environment Day (WED) with a Company-wide period dedicated to sustainability.
CSX (Nasdaq: CSX) was named to the Dow Jones Sustainability Index for North America for the seventh consecutive year, recognizing the company’s leadership in sustainable and responsible business practices. CSX was the only U.S.-based railroad and one of only three transportation companies included on the North American index in 2017.
Plastic and prisons: two of America’s most toxic habits. Happily there are people working to create alternatives. This week on Sea Change Radio we learn about a new type of flexible compostable packaging, developed by Israeli entrepreneur, Daphna Nissenbaum, who hopes this new polymer will take a bite out of the enormous problem of plastic waste. Next, we speak to Zoe Loftus-Farren about her Earth Island Journal piece that exposes the multitude of environmental hazards created by the prison industrial complex and America’s unhealthy addiction to locking people up.
Apple is a massive company with global influence. If they set ambitious goals, and then achieve them, the impact will be immense and go beyond their own balance sheet and impact report.
Maverick students will be able to cruise to classes when The University of Texas at Arlington’s Institute for Sustainability and Global Impact launches a new bike-sharing program Wednesday, Sept. 6. The program strengthens the University’s commitment to sustainability and enabling the modern megacity.
Carnival Cruise Line’s Captain Vittorio Marchi and other volunteers from Carnival Spirit worked shoulder to shoulder with the local community at Lifou in New Caledonia playing their part in an international movement to clean up the world's coast lines.
Trane Technologies is a global climate innovator with a clear purpose to boldly challenge what’s possible for a sustainable world. See how embedding...
Showcase Action Against Hunger’s pioneering role in advancing malnutrition treatment—from early therapeutic formulas (F100, F75) to ongoing innovation...